BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析

◆英語タイトル:BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1352
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioGaia AB (BIOG B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), straws and infant formulas. BioGaia’s products are based on various strains of Lactobacillus reuteri, its patented lactic acid bacterium. Its products improve the digestive and oral health of children and adults, and controls digestive problems such as colic, regurgitation, diarrhea and constipation. The company’ sells its products through distributors in the Americas, Europe and Asia-Pacific. BioGaia is headquartered in Stockholm, Sweden.

BioGaia AB Key Recent Developments

Mar 30,2020: BioGaia update concerning COVID-19 pandemic
Feb 11,2020: BioGaia’s oral health probiotic L. reuteri Prodentis reduces bleeding of the gums
Feb 06,2020: BioGaia – Year-end report 2019
Oct 23,2019: BioGaia interim management statement 1 January – 30 September 2019
Oct 10,2019: BioGaia: Reduced sales due to delivery delays

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioGaia AB – Key Facts
BioGaia AB – Key Employees
BioGaia AB – Key Employee Biographies
BioGaia AB – Major Products and Services
BioGaia AB – History
BioGaia AB – Company Statement
BioGaia AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioGaia AB – Business Description
Business Segment: Adult Health
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Pediatric
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA
Performance
BioGaia AB – SWOT Analysis
SWOT Analysis – Overview
BioGaia AB – Strengths
BioGaia AB – Weaknesses
BioGaia AB – Opportunities
BioGaia AB – Threats
BioGaia AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioGaia AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2020: BioGaia update concerning COVID-19 pandemic
Feb 06, 2020: BioGaia – Year-end report 2019
Oct 23, 2019: BioGaia interim management statement 1 January – 30 September 2019
Oct 10, 2019: BioGaia: Reduced sales due to delivery delays
Aug 08, 2019: BioGaia Interim report 1 January – 30 June 2019
Mar 18, 2019: Finland first market to launch BioGaia Protectis capsules
Feb 07, 2019: BioGaia– Year-end report 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioGaia AB, Key Facts
BioGaia AB, Key Employees
BioGaia AB, Key Employee Biographies
BioGaia AB, Major Products and Services
BioGaia AB, History
BioGaia AB, Other Locations
BioGaia AB, Subsidiaries
BioGaia AB, Key Competitors
BioGaia AB, Ratios based on current share price
BioGaia AB, Annual Ratios
BioGaia AB, Annual Ratios (Cont...1)
BioGaia AB, Annual Ratios (Cont...2)
BioGaia AB, Interim Ratios
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
BioGaia AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
BioGaia AB, Performance Chart (2015 - 2019)
BioGaia AB, Ratio Charts
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
BioGaia AB, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aixtron SE (AIXA):企業の財務・戦略的SWOT分析
    Aixtron SE (AIXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Petropavlovsk PLC:企業の戦略・SWOT・財務情報
    Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report Summary Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Seoul Semiconductor Co Ltd (046890):企業の財務・戦略的SWOT分析
    Summary Seoul Semiconductor Co Ltd (Seoul Semiconductor) is an electronic device manufacturing company that manufactures LED devices. The company provides products such as Acrich series, nPola, WICOP series, and others. It provides LED’s such as z-power LED, top view LED, through hole, side view LED …
  • Pacific Hydro Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Pacific Hydro Pty Ltd (Pacific Hydro), a subsidiary of State Power Investment Corporation is an energy solutions provider that undertakes the development and operations of the renewable power projects. The company offers wind, hydro, solar and geothermal power projects at varying stages of d …
  • Neftisa:石油・ガス:M&Aディール及び事業提携情報
    Summary Neftisa is an upstream oil and gas company. The company's activities include prospecting and development of hydrocarbon reservoirs, oil production, gas condensate recovery, conversion of oil associated gas, oil-and-gas fields development and extraction, maintenance and monitoring of oil serv …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • The Singing Machine Company, Inc.:戦略・SWOT・企業財務分析
    The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Singing Machine Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Titan Medical Inc (TMD):医療機器:M&Aディール及び事業提携情報
    Summary Titan Medical Inc (Titan) is a development stage company that designs and develops a robotic surgical system for application in minimally invasive surgery (MIS). The company's lead product candidate, single port robotic (SPORT) surgical system is a single-incision robotic surgical system. It …
  • CESC Limited:発電所・企業SWOT分析
    CESC Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • PT Mitra Adiperkasa Tbk:企業の戦略・SWOT・財務情報
    PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nido Petroleum Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Nido Petroleum Limited (Nido), a subsidiary of BCP Energy International Pte. Ltd, is an upstream energy company. It explores for, develops, and produces oil and gas. Nido holds working interests in exploration permits in the North West Palawan basin of the Philippines. The company operates t …
  • BioInvent International AB (BINV):製薬・医療:M&Aディール及び事業提携情報
    Summary BioInvent International AB (BioInvent) focuses on the discovery and development of antibody drugs for the treatment of cancer. The company uses n-CoDeR, its inhouse platform for developing immuno-oncology drugs. n-CoDeR is an antibody library used for the rapid selection, screening and ident …
  • Just the Berries Ltd:戦略・SWOT・企業財務分析
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析
    Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Cesca Therapeutics Inc (KOOL):製品パイプライン分析
    Summary Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device di …
  • Australian Mines Limited:企業の戦略・SWOT・財務情報
    Australian Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報
    Summary Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company produces tablet, capsule, and injection formulations and active pharmaceutical ingredients, among others. …
  • Alimentation Couche-Tard Inc. (ATD.B):企業の財務・戦略的SWOT分析
    Alimentation Couche-Tard Inc. (ATD.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Aimmune Therapeutics Inc (AIMT):製薬・医療:M&Aディール及び事業提携情報
    Summary Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆